Related Experiment Video
Updated: Jul 10, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Prospective study of pathogen burden and risk of myocardial infarction or death
1Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC 20010, USA.
Insights
Infections increase the risk of myocardial infarction (MI) and death in coronary artery disease (CAD) patients. Higher pathogen burden, from infections like CMV and HAV, correlates with increased risk.
Area of Science:
- Infectious Diseases
- Cardiovascular Medicine
- Immunology
Background:
- Previous cross-sectional studies linked pathogen burden to coronary artery disease (CAD) risk.
- This prospective study investigates pathogen burden's impact on myocardial infarction (MI) or death in CAD patients.
Purpose of the Study:
- To evaluate the effect of pathogen burden on the risk of MI or death in patients with established CAD.
- To determine if specific pathogens or overall pathogen load predict adverse cardiovascular events.
Main Methods:
- Prospective study of 890 CAD patients.
- Assessed IgG antibodies to various pathogens (CMV, HAV, HSV1, HSV2, C. pneumoniae, H. pylori) and C-reactive protein (CRP) levels.
- Followed patients for a mean of 3 years to record MI or death events.
Main Results:
- Higher prevalence of antibodies to CMV, HAV, HSV1, and HSV2 was observed in patients who later experienced MI or death.
- Increased pathogen burden was significantly associated with a dose-response increase in MI or death risk.
- Adjusted relative hazards for MI or death were elevated for CMV, HAV, and HSV2 infections, independent of CRP levels.
Conclusions:
- Infections play a significant role in incident MI or death among CAD patients.
- The risk posed by infection is independently related to the overall pathogen burden.
Background:
We previously demonstrated that the risk of coronary artery disease (CAD) increased in relation to the number of pathogens (the "pathogen burden") in a cross-sectional study. In the present prospective study with a different patient cohort, we evaluated the effect of pathogen burden on the risk of myocardial infarction (MI) or death among CAD patients.
Methods And Results:
IgG antibodies to cytomegalovirus (CMV), hepatitis A virus (HAV), herpes simplex virus type 1 (HSV1), HSV type 2 (HSV2), Chlamydia pneumoniae and Helicobacter pylori, and C-reactive protein (CRP) levels were tested in baseline blood samples from 890 patients who had significant CAD on angiography. The mean follow-up period was 3 years. The baseline prevalence of antibodies directed against CMV, HAV, HSV1, or HSV2, but not C pneumoniae and H pylori, was significantly higher among patients who subsequently developed MI or death than among control subjects. After adjustment for traditional risk factors, number of diseased vessels, and clinical presentation, relative hazards (95% confidence limits) for MI or death were 2.0 (1. 4 to 3.2) for CMV, 1.6 (1.1 to 2.3) for HAV, and 1.5 (1.0 to 2.2) for HSV2. Increasing pathogen burden was significantly associated with increasing risk of MI or death in a dose-response fashion. Adjusted relative hazards of MI or death associated with pathogen burden were significant among individuals with low or high CRP levels.
Conclusions:
The results suggest that infection plays an important role in incident MI or death and that the risk posed by infection is independently related to the pathogen burden.
Related Concept Videos
Endocarditis I: Introduction
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Diphtheria

